Retrospective analysis of the results of high-dose chemotherapy with the support of autologous blood stem cells in patients with multiple myeloma. The experience of a single centre.

Prague medical report

Volumn 111, Issue 3, 2010, Pages 207-218

  Koren J ^a   Spicka I ^b   Straub, J ^b   Vackova B ^b   Trnkova M ^b   Pohlreich, D ^b   Pytlik R ^b   Trneny M ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; REMISSION; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MULTIPLE MYELOMA; REMISSION INDUCTION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING;

EID: 79952050486     PISSN: 12146994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)